






























prepared	 and	 reacted	with	 several	 acids,	 either	 commercially	 available	 or	 prepared.	 These
included,	 aliphatic	 or	 aromatic	 acids	 (phenylacetic	 acid	 derivatives,	 benzoic	 derivatives),
palmitic	 acid	 and	 the	 protected	 amino	 acids	 N‐(benzyloxycarbonyl)glycine	 and	 N‐(tert‐
butyloxycarbonyl)‐phenylalanine.	 Two	 other	 acids,	 2‐(3‐bromopropoxy)benzoic	 acid	 and	 2‐
(5‐bromopentoxy)benzoic	 acid	 (analogues	 of	 salicylic	 acid	 were	 synthesized),	 whose
preparation	is	also	described	in	this	work.	The	esterification	was	performed	either	with	N,N'‐












Salicylic	 acid	 derivatives	 are	 widely	 known	 either	 as	
natural	products	or	as	synthetic	derivatives	and	they	are	often	
used	 for	 their	 biological	 properties,	 such	 as	 antibacterial	 [1],	





antimicrobial	 activity	 [8].	 Nonsteroidal	 anti‐inflammatory	
drugs	 (NSAIDs)	 are	 the	 most	 commonly	 used	 agents	 for	 the	
treatment	of	pain	and	 inflammation.	The	prototype	of	NSAIDs	
is	 aspirin,	 which	 displays	 anti‐inflammatory	 and	 analgesic	
properties,	 and	 also	 antithrombotic	 effects,	 thus	 protecting	
against	ischemic	vascular	disorders	[9].	
Biocompatible	 non‐ionic	 surfactants	 can	 be	 obtained	 by	
linking	 a	 hydrophobic	 alkyl	 chain	 to	 a	 polyhydroxylated	
system,	 usually	 a	 carbohydrate	 molecule,	 through	 ester	
linkages.	 The	 surface‐active	 behavior	 of	 these	 esters	 depends	
on	 the	 length	of	 the	 lipophilic	chain,	 the	 temperature,	and	 the	
position	of	the	ester	group	in	the	hydrophilic	head	of	the	sugar.	
Surfactants	 are	 molecules	 which	 exert	 a	 wide	 range	 of	
biological	activity	[10].	
Glycoconjugates,	 namely	 glycopeptides,	 have	 great	
potential	 in	 drug	 design,	 since	 they	 mimic	 fragments	 of	
glycoproteins	 but	 they	 are	 smaller	 and	 simpler	 [11‐16].	 The	
sugar	 moiety	 influences	 the	 drug	 molecules	 behavior	 and	
enhances	 the	 transport	 through	 cell	membranes	 [17‐20].	 In	 a	




this	 work,	 combining	 the	 1,2,3‐triazole	 unit	 and	 the	 acid	
components,	 may	 have	 interesting	 biological	 properties.	 Two	
examples	of	a	similar	type,	in	the	literature,	are	the	assessment	
as	 potential	 glycosidase	 inhibitors	 [22]	 of	 a	 set	 of	 β‐D‐
glucopyranosyl	 triazoles,	 and	 the	 preparation	 of	 esters	
derivatives	 of	 1,2,3‐triazole	 glycosides	 showing	 cell	 growth	
inhibition	against	two	cell	strains:	NCI‐H292	(Lung	carcinoma)	
and	HEp‐2	(larynx	carcinoma)	[23].	
Recently,	 we	 became	 interested	 in	 the	 use	 of	 click	
chemistry	 [24,25]	 to	 form	 a	 triazole	 bridge	 to	 carbohydrates	
[26].	 The	 1,2,3‐triazole	 unit	 can	 mimic	 the	 length	 and	 bond	
angles	 of	 the	 amide	 bond,	 displaying	 resistance	 to	 hydrolysis	




chemistry”	 to	 synthesize	 ester	derivatives	of	 sugars.	Copper(I)	
1,3‐dipolar	 azide‐alkyne	 cycloaddition	 (click	 reaction)	 proved	
to	 be	 an	 useful	 synthetic	 process	 to	 obtain	 1,4‐dissubstituted	
1,2,3‐triazole	glycosides	and	it	was	used	to	prepare	the	starting	
alcohol	 1	 for	 esterification	 (Figure	 1).	 The	 acid	 components	
included	 amino	 acids,	 palmitic	 acid,	 phenyl	 acetic	 acid	 and	












Plus	 Spectrometer	 at	 298	 K	 or	 on	 a	 Bruker	 Avance	 III	 400	




(heteronuclear	 multiple	 bond	 correlation)	 experiments	 were	
carried	out	for	complete	assignment	of	1H	and	13C	signals	in	the	
NMR	spectra.	High‐resolution	mass	spectra	were	obtained	on	a	
Bruker	 FTMS	 APEXIII	 spectrometer.	 Elemental	 analyses	were	
obtained	on	a	Leco	CHNS‐932	instrument.	TLC	was	carried	out	
on	 plates	 coated	 with	 silica	 gel	 60F254.	 Column	 chroma‐
tography	 was	 performed	 on	 silica	 gel	 (70‐230	 or	 230‐400	
mesh).	 Light	 petroleum	 refers	 to	 the	 fraction	 boiling	 in	 the	
range	40‐60	oC.	Specific	optical	rotations	were	calculated	from	
measurements	 carried	 out	 with	 an	 Optical	 Activity‐AA‐1000	









triazol‐1‐yl]‐β‐D‐glucopyranose	 (1):	 To	 a	 solution	 of	 α‐ABG	
(1.244	 g,	 3	 mmol)	 in	 DMSO	 (15	 mL)	 dry	 NaN3	 (0.236	 g,	 3.6	
mmol)	was	 added.	 The	 reaction	mixture	was	 stirred	 at	 room	
temperature	for	20	minutes	followed	by	addition	of	but‐3‐yn‐1‐
ol	 (0.34	mL,	4.5	mmol),	 sodium	L‐ascorbate	1	M	 solution	 (7.5	
mL)	 and	CuSO4.5H2O	1	M	solution	 (7.5	mL).	 The	mixture	was	
stirred	 at	 room	 temperature	 for	 further	 60	 mins	 and	 a	 solid	
was	 filtered	 off,	 and	water	 (60	mL)	was	 added	 to	 the	 filtrate.	
The	mixture	was	 extracted	with	 ethyl	 acetate	 (4x50	mL),	 the	
combined	 extracts	 were	 dried	 (MgSO4)	 and	 the	 solvent	 was	
removed	 under	 reduced	 pressure	 giving	 an	 oily	 product.	 The	






2.1	 Hz,	 1H,	 H‐6a),	 4.12	 (dd,	 J	 =	 12.3,	 5.1	 Hz,	 1H,	 H‐6b),	 4.34	
(ddd,	 J	=	9.6,	5.1,	2.1	Hz,	1H,	H‐5),	4.71	(t,	J	=	5.4	Hz,	1H,	OH),	
5.15	 (t,	 J	 =	9.6	Hz,	1H,	H‐4),	 5.53	 (t,	 J	 =	9.3	Hz,	1H,	H‐3),	5.61	
(apt,	J	=	9.6/8.7	Hz,	1H,	H‐2),	6.28	(d,	J	=	8.7	Hz,	1H,	H‐1),	8.13	
(s,	1H,	H‐5´).	13C	NMR	(75.4	MHz,	DMSO‐d6,	δ,	ppm):	19.8	(Me‐
C‐2),	 20.2	 (Me‐C‐3),	 20.3	 (Me‐C‐6),	 20.4	 (Me‐C‐4),	 28.9	 (CH2),	
60.1	(CH2O),	61.8	(C‐6),	67.5	(C‐4),	70.0	(C‐2),	72.2	(C‐3),	73.1	
(C‐5),	 83.6	 (C‐1),	 121.6	 (C‐5’),	 144.9	 (C‐4’),	 168.4	 (CO‐C‐2),	
169.3	(CO‐C‐4),	169.5	(CO‐C‐3),	170.0	(CO‐C‐6).	ESI‐MS	(m/z):	
calcd.	for	C18H25N3O10:	443.15;	found:	466.42	(M+Na)+.	
2‐(5‐Bromopentoxy)benzoic	 acid	 (2):	 To	 a	 solution	 of	
salicylaldehyde	 (2.00	 g,	 16.3	mmol)	 in	 acetonitrile	 (100	mL),	
1,5‐dibromopentane	(4.5	g,	19.6	mmol)	and	K2CO3	(4.52	g,	32.6	
mmol)	 were	 added	 and	 the	 reaction	 mixture	 was	 stirred	 at	
room	temperature	for	40	h.	Then,	dichloromethane	and	water	
were	 added	 and	 the	 organic	 layer	 was	 washed	 with	 water,	
dried	(Na2SO4)	and	the	solvent	was	evaporated	giving	a	brown‐
orange	 oil.	 Purification	 by	 column	 chromatography	 (elution	
with	mixtures	of	light	petroleum	and	ethyl	acetate	of	increasing	
polarity)	 gave	 the	 2‐(5‐bromopentoxy)benzaldehyde	 as	 a	
yellow	oil	(1.00	g,	22.6%).	
The	above	derivative	was	dissolved	in	acetonitrile	(10	mL)	
and	 cooled	 to	 0	 oC.	 A	0.1	M	 aqueous	 solution	of	 KMnO4	 (55.4	
mL,	 5.5	mmol)	was	 added	dropwise	 and	 the	mixture	was	 left	
stirring	 for	 36	 hrs.	 The	 solid	 was	 filtered	 and	 washed	 with	
acetonitrile.	 The	 solvent	 was	 evaporated	 and	 the	 residue	
acidified	 to	 pH	 =	 2	 (with	 2	 M	 HCl)	 and	 extracted	 with	 ethyl	








δ,	ppm):	24.6	 (CH2‐C‐3’),	27.7	 (CH2‐C‐2’),	32.2	 (CH2‐C‐4’),	33.3	
(CH2‐Br),	 64.9	 (CH2‐O),	 112.4	 (C‐1),	 117.5	 (C‐3),	 119.1	 (C‐5),	






A	 solution	 of	 the	 alcohol	 1	 (0.325	 mmol,	 2,3,4,6‐tetra‐O‐
acetyl‐1‐[4‐(2‐hydroxy‐ethyl)‐1H‐1,2,3‐triazol‐1‐yl]‐β‐D‐gluco	
pyranose),	 DCC	 (0.358	 mmol),	 the	 acid	 (0.325	 mmol)	 and	
DMAP	(0.325	mmol)	in	dichloromethane	(8	mL)	was	stirred	at	






triazol‐1‐yl]‐β‐D‐glucopyranose	 (3):	 The	 compound	 was	
prepared	from	phenyl	acetic	acid	(1.15	mmol),	and	purified	by	
recrystallization	 (ethyl	 acetate	 and	 light	 petroleum)	 followed	
by	PLC	 (ethyl	acetate:	 light	petroleum;	1:1)	and	recrystallized	
again.	A	white	solid	(0.26	g)	was	obtained	in	40%	yield	(Figure	
1).	M.p.:	122.4‐123.9	oC.	 [α]D25.5:	 ‐15.4	(c	0.02,	CHCl3).	 1H	NMR	






13C	 NMR	 (75.4	MHz,	 DMSO‐d6,	 δ,	 ppm):	 19.9,	 20.3,	 20.4,	 20.5	
(4xMe‐(CO)),	 24.8	 (CH2),	 40.3	 (CH2Ar),	 61.8	 (C‐6),	 63.0	 (CH2),	
67.6	 (C‐4),	70.1	(C‐2),	72.2	 (C‐3),	73.2	 (C‐5),	83.7	 (C‐1),	121.7	






1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 (4):	 The	 compound	 was	
prepared	 from	 4‐nitrophenyl	 acetic	 acid	 (1.13	 mmol),	 and	
purified	 by	 column	 chromatography	 (mixtures	 of	 light	
petroleum	 and	 ethyl	 acetate	 of	 increasing	 polarity)	 giving	 a	
thick	oil	which	yielded,	on	standing,	a	white	solid	(0.52	g,	76%)	
(Figure	1).	M.p.:	97.6‐99.1	 oC.	 [α]D25.5:	 ‐17.6	 (c	0.02,	CHCl3).	 1H	











142.3	 (C‐1”),	 143.9	 (C‐4’),	 146.5	 (C‐4”),	 168.5,	 169.4,	 169.6,	




triazol‐1‐yl]‐β‐D‐glucopyranose	 (6):	 The	 compound	 was	
prepared	 from	 diphenyl	 acetic	 acid	 (0.25	mmol),	 filtered	 and	
recrystallized	 from	 ethyl	 acetate	 and	 light	 petroleum.	A	 beige	

















5.60	 (m,	2H,	H‐2	and	H‐3),	 6.28	 (d,	 J	 =	8.7	Hz,	1H,	H‐1),	7.20‐
7.38	 (m,	 10H,	 Ar‐H),	 7.94	 (s,	 1H,	 H‐5’).	 13C	 NMR	 (75.4	 MHz,	
DMSO‐d6,	δ,	ppm):	19.9,	20.3,	20.4,	20.5	(4xMe‐CO),	24.7	(CH2),	
55.8	(CH),	61.9	(C‐6),	63.5	(CH2),	67.5	(C‐4),	70.1	(C‐3),	72.1	(C‐
2),	 73.2	 (C‐5),	 83.7	 (C‐1),	 121.6	 (C‐5’),	 127.1,	 128.5,	 128.5,	





1H‐1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 (7):	 The	 compound	
was	prepared	 from	4‐methoxyphenyl	acetic	acid	 (0.45	mmol),	
filtered	 and	 recrystallized	 from	 ethyl	 acetate	 and	 light	
petroleum.	 A	 light	 brown	 solid	 was	 obtained	 (0.149	 g,	 56%)	
(Figure	1).	M.p.:	101.6‐103.2	oC.	[α]D25.5:	‐13.5	(c	0.02,	CHCl3).	1H	








d6,	 δ,	 ppm):	 19.9,	 20.2,	20.4,	 20.5	 (4xMe‐CO),	 24.8	 (CH2),	 39.3	
(CH2Ar),	55.0	(OMe),	61.8	(C‐6),	62.9	(CH2),	67.6	(C‐4),	70.1	(C‐
3),	 72.2	 (C‐2),	 73.2	 (C‐5),	 83.8	 (C‐1),	 113.7	 (C‐2”	 and	 C‐6”),	
121.7	 (C‐5’),	 126.2	 (C‐1”),	 130.4	 (C‐3”	 and	C‐5”),	 143.9	 (C‐4’),	
158.1	 (C‐4”),	 168.5,	 169.4,	 169.6,	 170.0,	 171.4	 (C=O).	 ESI‐MS	




1H‐1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 (8):	 The	 titled	
compound	was	prepared	from	4‐chlorophenyl	acetic	acid	(0.45	
mmol)	 and	 purified	 by	 column	 chromatography	 (mixtures	 of	
light	 petroleum	 and	 ethyl	 acetate	 of	 increasing	 polarity)	
followed	 by	 recrystallization	 from	 ethyl	 acetate	 and	 light	
petroleum	 (0.174	 g,	 65%)	 (Figure	 1).	 M.p.:	 131.6‐133.4	 oC.	







(d,	 J	 =	8.5	Hz,	2H,	H‐2”	 and	H‐6”),	 8.19	 (s,	 1H,	H‐5’).	 13C	NMR	
(100.6	MHz,	 DMSO‐d6,	 δ,	 ppm):	 19.9,	 20.2,	 20.4,	 20.5	 (4x	Me‐
CO),	24.7	(CH2),	39.3	(CH2Ar),	61.8	(C‐6),	63.1	(CH2),	67.6	(C‐4),	
70.1	(C‐3),	72.2	(C‐2),	73.2	(C‐5),	83.8	(C‐1),	121.7	(C‐5’),	128.2	
(C‐2”	and	C‐6”),	131.3	 (C‐3”	and	C‐5”),	 131.5	 (C‐1”),	133.3	 (C‐
4”),	 143.9	 (C‐4’),	 168.5,	 169.4,	 169.6,	 170.0,	 170.8	 (C=O).	 ESI‐
MS	 (m/z):	 calcd.	 for	 C26H30ClN3O11:	 595.98;	 found:	 618.42	
(M+Na)+.	 Anal.	 Calcd.	 for	 C26H30ClN3O11:	 C,	 52.40;	 H,	 5.07;	 N,	
7.05.	Found:	C,	52.38;	H,	5.03;	N	7.06%.	
2,3,4,6‐Tetra‐O‐acetyl‐1‐[4‐(2‐bromopropoxybenzoyloxy	
ethyl)‐1H‐1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 (10):	 The	 titled	
compound	 was	 from	 2‐(5‐bromopropoxy)benzoic	 acid	 (0.40	
mmol)	 and	 alcohol	 1.	 The	 amounts	 of	 other	 reagents	 and	
solvents	 were	 adjusted	 accordingly.	 The	 oil	 obtained	 was	
crystallized	 from	 ethyl	 acetate‐light	 petroleum	 affording	 a	
white	 solid	 (0.246	 g,	 90%)	 (Figure	 1).	 M.p.:	 122.3‐123.4	 oC.	












113.6	 (C‐3”),	 120.0	 (C‐1”),	 120.3	 (C‐4”	 or	 C‐5”),	 121.8	 (C‐5’),	
131.0	 (C‐6”),	 133.8	 (C‐4”	 or	 C‐5”),	 144.1	 (C‐4’),	 157.6	 (C‐2”),	
165.4,	 168.5,	 169.4,	 169.6,	 170.1	 (C=O).	 ESI‐HRMS:	 Calcd.	 for	
C28H35BrN3O12:	 684.13986	 [M+H]+;	 found	 684.13987.	 Anal.	




The	 compound	 was	 prepared	 from	 N‐(benzyloxycarbonyl)‐L‐
glycine	(0.56	mmol).	All	other	reagents	and	solvents	were	used	









Hz,	 1H,	 H‐1),	 7.22‐7.50	 (m,	 5H,	 Ar‐H),	 7.67	 (t,	 J	 =	 6.0	Hz,	 1H,	
NH),	8.23	(s,	1H,	H‐5’).	13C	NMR	(75.4	MHz,	DMSO‐d6,	δ,	ppm):	
19.9,	 20.2,	 20.4,	 20.5	 (4x	 Me‐CO),	 24.7	 (CH2),	 42.1	 (CH2Gly),	
61.8	(C‐6),	63.1	(CH2),	65.6	(CH2Z),	67.5	(C‐4),	70.1	(C‐2),	72.1	
(C‐3),	73.2	(C‐5),	83.7	(C‐1),	121.8	(C‐5’),	127.8	(C‐2”	and	C‐6”),	
127.9	 (C‐4”),	128.4	 (C‐3”	and	C‐5”),	 136.9	 (C‐1”),	143.8	 (C‐4’),	
156.5	 (CO‐Z),	 168.5	 (CO‐C‐2),	 169.4	 (CO‐C‐4),	 169.6	 (CO‐C‐3),	




pyranose	 (12):	 The	 compound	 was	 prepared	 from	 N‐(tert‐
butoxycarbonyl)‐L‐phenylalanine	 (0.56	 mmol).	 All	 other	
reagents	 and	 solvents	 were	 used	 in	 appropriate	 amounts.	 A	
greenish	oily	solid	was	obtained	which	was	recrystallized	twice	





CH2O),	 4.30	 –	 4.40	 (m,	 1H,	H‐5),	 5.14	 (t,	 J	 =	 9.6	Hz,	 1H,	H‐4),	
5.50‐5.64	 (m,	 2H,	H‐2	 and	H‐3),	 6.30	 (d,	 J	 =	 8.4	Hz,	 1H,	H‐1),	
7.18‐7.28	 (m,	 6H,	 Ar‐H	 and	 NH),	 8.22	 (s,	 1H,	 H‐5’).	 D2O	
exchange	showed	simplification	on	the	multiplet	at	2.75	–	3.00	
ppm.	 13C	NMR	 (75.4	MHz,	DMSO‐d6,	 δ,	 ppm):	 19.8,	 20.2,	 20.3,	
20.4	 (4xMe‐CO),	 24.7	 (CH2),	 27.7,	 28.1	 (3xMe‐Boc),	 36.2	 (β‐
CH2),	55.2	(α‐CH),	61.7	(C‐6),	63.0	(CH2),	67.5	(C‐4),	70.1	(C‐3),	
72.1	 (C‐2),	 73.1	 (C‐5),	 78.2	 (C‐Boc),	 83.7	 (C‐1),	 121.7	 (C‐5’),	
126.4,	 128.1,	 129.0	 (Ar‐H),	 137.5	 (Cq,	 Ar),	 143.7	 (C‐4’),	 155.4	
(CO‐Boc),	 168.4,	 169.3,	 169.5,	 169.9	 (4xCO‐Me),	 172.0	 (CO‐
Phe).	 ESI‐HRMS:	 Calcd.	 for	 C32H43N4O13,	 691.28211	 [M+H]+;	
found	691.28201.	
2,3,4,6‐Tetra‐O‐acetyl‐1‐[4‐palmitoyloxyethyl)‐1H‐1,2,3‐
triazol‐1‐yl]‐β‐D‐glucopyranose	 (13):	 The	 compound	 was	
prepared	in	0.6	mmol	scale,	using	palmitic	acid	and	the	alcohol	
1	 as	 the	 starting	 materials.	 A	 greenish	 solid	 was	 obtained	
(0.139	g,	34%)	(Figure	1).	M.p.:	120‐124	oC.	[α]D21:	‐12.2	(c	1.0,	
CHCl3).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	0.84	(t,	J	=	7.2	Hz,	
















ethyl)‐1H‐1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 (14):	 The	 titled	
compound	 was	 prepared	 from	 2‐(5‐bromopentyloxy)benzoic	
acid	(1.72	mmol)	and	alcohol	1.	The	amounts	of	other	reagents	
and	 solvents	 were	 adjusted	 accordingly.	 The	 compound	 was	
purified	 by	 chromatography	 with	 ethyl	 acetate‐petroleum	
ether	3:2,	yielding	a	white	solid	(0.723	g,	59%)	(Figure	1).	M.p.:	
70.4‐71.2	 oC.	 [α]D21:	 ‐19.4	 (c	 1.0,	 CHCl3).	 1H	 NMR	 (300	 MHz,	
DMSO‐d6,	 δ,	 ppm):	 1.48‐1.60	 (m,	 2H,	 CH2),	 1.64‐1.74	 (m,	 2H,	










or	CH2O),	63.1	 (CH2OCO),	67.6	 (C‐4),	68.0	 (C‐6	or	CH2O),	70.1	
(C‐3),	72.2	(C‐2),	73.2	(C‐5),	83.7	(C‐1),	113.5	(C‐3”),	120.0	(C‐
5”),	120.2	(C‐1”),	121.7	(C‐5’),	130.7	(C‐6”),	133.5	(C‐4”),	144.0	








(10	mL)	at	0	 	 oC,	acyl	chloride	(0.44	mmol)	and	 triethylamine	
(0.44	mmol)	were	added.	The	 reaction	mixture	was	 stirred	at	




and	 the	 solvent	 was	 removed	 under	 reduced	 pressure.	 The	
resulting	 product	 was	 purified	 either	 by	 column	
chromatography	or/and	recrystallization.	
2,3,4,6‐Tetra‐O‐acetyl‐1‐[(4‐benzoyloxyethyl)‐1H‐1,2,3‐
triazol‐1‐yl]‐β‐D‐glucopyranose	 (5):	 This	 compound	 was	
prepared	 from	 benzoyl	 chloride	 (0.86	 mmol).	 The	 organic	
extract	 obtained	 was	 an	 oil	 that	 after	 treatment	 with	 ethyl	
ether	gave	a	white	solid	(0.282	g,	60%)	(Figure	1).	M.p.:	166.0‐
167.8	 oC.	 [α]D25.5:	 ‐19.6	 (c	 0.02,	 CHCl3).	 1H	 NMR	 (300	 MHz,	
DMSO‐d6,	 δ,	 ppm):	 1.69,	 1.95,	 1.97,	 2.02	 (4s,	 12H,	 4xMe‐CO),	






19.8,	 20.3,	 20.4,	 20.5	 (4xMe‐CO),	 24.9	 (CH2),	 61.8	 (C‐6),	 63.5	
(CH2),	67.6	(C‐4),	70.1	(C‐3),	72.2	(C‐2),	73.2	(C‐5),	83.7	(C‐1),	
121.8	(C‐5’),	128.7	(C‐3”	and	C‐5”),	129.2	(C‐2”	and	C‐6”),	129.7	
(C‐1”),	 133.3	 (C‐4”),	 144.1	 (C‐4’),	 165.7,	 168.4,	 169.4,	 169.6,	




1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 (9):	 The	 compound	 was	
prepared	 from	3,5‐dinitrobenzoyl	 chloride	 (0.40	mmol)	 and	 a	
reaction	 time	of	4	hours.	An	oily	product	was	obtained	which	
was	 purified	 by	 column	 chromatography	 (silica,	 solvent	 of	
increasing	 polarity	 of	 mixtures	 of	 petroleum	 ether	 and	 ethyl	
acetate).	 The	 obtained	 solid	 was	 recrystallized	 from	 ethyl	
acetate	and	 light	petroleum	yielding	a	white	powder	(0.140	g,	











6”),	 132.7	 (C‐1”),	 143.9	 (C‐4’),	 148.4	 (C‐3”	 and	 C‐5”),	 162.5,	








mL)	 and	 DCM	 (10	 mL)	 and	 set	 aside	 for	 3.5	 hrs	 at	 room	
temperature.	 Solvents	 were	 removed	 and	 the	 residue	 was	
purified	 by	 column	 chromatography	 (mixtures	 of	 light	









7.35	 (m,	 >5	 H,	 Ar‐H),	 8.07	 (s,	 1H,	 H‐5’).	 The	 sample	 was	




29.8	 (CH2),	40.4	 (β‐CH2),	56.2	 (α‐CH),	61.9	 (CH2O),	63.0	 (C‐6),	
69.2	(C‐4),	71.9	(C‐3	or	C‐2),	74.2	(C‐2	or	C‐3),	75.9	(C‐5),	86.5	
(C‐1),	 123.7	 (C‐5’),	 137.4	 (Cq‐Ar),	 147.0	 (C‐4’),	 170.4,	 171.2,	





The	 reaction	 of	 2,3,4,6‐tetra‐O‐acetyl‐β‐D‐glucopyranosyl	
azide	 (prepared	 in	 situ	 from	 α‐acetobromoglucose	 (α‐ABG)	
upon	 reaction	 with	 NaN3	 in	 DMSO)	 [29]	 with	 but‐3‐yn‐1‐ol	
alcohol	 under	 click	 chemistry	 conditions	 [29,30]	 afforded	 the	
alcohol	 (1)	 with	 an	 overall	 yield	 of	 47%.	 The	 presence	 of	 a	
singlet	at	8.13	ppm	for	 the	H‐5	of	 the	 triazole	 ring,	 as	well	 as	
the	 expected	 signals	 for	 CH2CH2OH	 confirms	 the	 structure	 of	
the	alcohol.		
For	the	synthesis	of	the	esters,	commercial	reagents	such	as	
benzoic	 acid,	 3,5‐dinitrobenzoic	 acid,	 phenyl	 acetic	 acid,	 p‐
nitrophenyl	 acetic	 acid,	 p‐methoxyphenyl	 acetic	 acid,	 p‐
chlorophenyl	 acetic	 acid,	diphenylacetic	 acid,	palmitic	 acid,	N‐
(benzyloxycarbonyl)glycine	 and	 N‐(tert‐butyloxycarbonyl)‐
phenylalanine	were	used	as	acid	components.	Two	other	acids	
were	 synthesized,	 2‐(3‐bromopropoxy)benzoic	 acid	 [31,32]	
and	 2‐(5‐bromopentoxy)benzoic	 acid	 (2)	 described	 in	 this	
work.	The	latter	was	prepared	by	alkylation	of	salicylaldehyde	
with	 1,5‐dibromopentane	 followed	 by	 KMnO4	 oxidation	 in	 a	
global	yield	of	15%.	
The	 esterification	 was	 achieved	 either	 with	 DCC/DMAP	
(method	A)	or	by	reacting	the	acyl	chlorides	with	the	alcohol	in	
the	presence	of	triethylamine	(method	B).	The	yields	obtained	
ranged	 between	 34	 and	 90%	 by	 DCC/DMAP	 method.	 The	
dinitrobenzoic	 acid	 derivative	 (9)	was	 prepared	 in	 55%	yield	
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compound	3,	 3.86	 ppm	 for	 compound	4.	 The	 1H‐NMR	 for	 the	
amino	 acid	 containing	 derivatives	 shows	 the	 singlet	 for	 three	
CH3	 groups	 at	 1.32	 ppm	 for	 compound	12,	 and	 a	 doublet	 (J=	
5.7)	at	3.76	ppm	 for	 the	glycine	CH2,	11.	For	 the	ester	13	 the	
significant	signals	for	the	terminal	protons	of	the	alkyl	chain	at	
0.84	 (t,	CH3)	and	at	4.22	(t,	CH2O)	were	observed.	On	 the	 13C‐
NMR	spectra	the	expected	signals	were	observed	namely	CH2O	
at	24.8	 and	C‐4’	 and	C‐5’	 of	 triazole	 ring	at	 around	143.9	and	
121.7	ppm,	respectively.	Ester	15	was	prepared	by	the	removal	
of	 the	Boc	 (protective	 group	 of	 compound	12)	 and	 in	 the	 1H‐





A	 series	of	 esters	derived	 from	2,3,4,6‐tetra‐O‐acetyl‐1‐[4‐
(2‐hydroxyethyl)‐1H‐1,2,3‐triazol‐1‐yl]‐β‐D‐glucopyranose	 and	
carboxylic	 acids,	 either	 aliphatic	 or	 aromatic	 and	 amino	 acids	
were	 prepared.	 The	 methods	 used	 (DCC/DMAP	 or	 acyl	
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